| MeSH term | MeSH ID | Detail |
|---|---|---|
| Viremia | D014766 | 4 associated lipids |
| AIDS Dementia Complex | D015526 | 4 associated lipids |
| Neoplasms, Germ Cell and Embryonal | D009373 | 4 associated lipids |
| Burns, Inhalation | D002059 | 4 associated lipids |
| Shock, Traumatic | D012774 | 4 associated lipids |
| Asphyxia Neonatorum | D001238 | 4 associated lipids |
| Hypertrophy, Right Ventricular | D017380 | 4 associated lipids |
| Brain Injuries | D001930 | 4 associated lipids |
| Hepatitis B, Chronic | D019694 | 4 associated lipids |
| Lymphoma, T-Cell, Cutaneous | D016410 | 4 associated lipids |
Platelet activating factor
Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.
Cross Reference
Introduction
To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Platelet activating factor?
Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Platelet activating factor
PubChem Associated disorders and diseases
What pathways are associated with Platelet activating factor
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Platelet activating factor?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Platelet activating factor?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Platelet activating factor?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Platelet activating factor?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Platelet activating factor?
Knock-out
Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).
Mouse Model
Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).
Transgenic Model
Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with Platelet activating factor
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Iwase M et al. | Cardiac functional and structural alterations induced by endotoxin in rats: importance of platelet-activating factor. | 2001 | Crit. Care Med. | pmid:11373429 |
| Jehle R et al. | Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia. | 2001 | Biochim. Biophys. Acta | pmid:11420174 |
| Kulikov VI and Muzya GI | Inhibition of human platelet aggregation by amides and ester of salicylic acid with platelet-activating factor analogs. | 2001 | Biochemistry Mosc. | pmid:11421815 |
| Virchow JC et al. | Effect of a specific cysteinyl leukotriene-receptor 1-antagonist (montelukast) on the transmigration of eosinophils across human umbilical vein endothelial cells. | 2001 | Clin. Exp. Allergy | pmid:11422147 |
| Ferland C et al. | Eotaxin promotes eosinophil transmigration via the activation of the plasminogen-plasmin system. | 2001 | J. Leukoc. Biol. | pmid:11358986 |
| McManus LM et al. | Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. | 2001 | J. Leukoc. Biol. | pmid:11527989 |
| Qian C et al. | Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor. | 2001 | Pharmacol. Res. | pmid:11529688 |
| Bachert C | Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. | 2001 | Allergy | pmid:11243500 |
| Roudebush WE et al. | Impact of blood serum insulin-like growth factor I on platelet-activating factor in bull spermatozoa. | 2001 | Domest. Anim. Endocrinol. | pmid:11164329 |
| Giménez R and Aguilar J | Cytidine (5') diphosphocholine-induced decrease in cerebral platelet activating factor is due to inactivation of its synthesizing enzyme cholinephosphotransferase in aged rats. | 2001 | Neurosci. Lett. | pmid:11165772 |
| Goudevenos J et al. | Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplasty. | 2001 | Eur. J. Clin. Invest. | pmid:11168434 |
| Galimi F et al. | Hepatocyte growth factor is a regulator of monocyte-macrophage function. | 2001 | J. Immunol. | pmid:11145707 |
| Beales IL | Effect of platelet-activating factor on gastrin release from cultured rabbit G-cells. | 2001 | Dig. Dis. Sci. | pmid:11284466 |
| McHowat J et al. | Endothelial cell PAF synthesis following thrombin stimulation utilizes Ca(2+)-independent phospholipase A(2). | 2001 | Biochemistry | pmid:11732912 |
| Sirolli V et al. | Platelet activation and platelet-erythrocyte aggregates in end-stage renal disease patients on hemodialysis. | 2001 | Thromb. Haemost. | pmid:11583316 |
| Fukunaga K et al. | Single nucleotide polymorphism of human platelet-activating factor receptor impairs G-protein activation. | 2001 | J. Biol. Chem. | pmid:11560941 |
| Johnson CD et al. | Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. | 2001 | Gut | pmid:11115824 |
| Grosman N | Similar effects of ether phospholipids, PAF and lyso-PAF on the Ca(2+)-ATPase activity of rat brain synaptosomes and leukocyte membranes. | 2001 | Int. Immunopharmacol. | pmid:11460312 |
| Marathe GK et al. | Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids. | 2001 | J. Lipid Res. | pmid:11518762 |
| Thomet OA et al. | Role of petasin in the potential anti-inflammatory activity of a plant extract of petasites hybridus. | 2001 | Biochem. Pharmacol. | pmid:11286996 |
| Smith DG et al. | Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat. | 2001 | J. Neurovirol. | pmid:11519483 |
| Hoenstein R et al. | Interleukin-2 activates human peripheral blood eosinophils. | 2001 | Cell. Immunol. | pmid:11520078 |
| Carceller E et al. | Novel azo derivatives as prodrugs of 5-aminosalicylic acid and amino derivatives with potent platelet activating factor antagonist activity. | 2001 | J. Med. Chem. | pmid:11520209 |
| Burke JR et al. | BMS-229724 is a tight-binding inhibitor of cytosolic phospholipase A2 that acts at the lipid/water interface and possesses anti-inflammatory activity in skin inflammation models. | 2001 | J. Pharmacol. Exp. Ther. | pmid:11408565 |
| Uhlmann D et al. | Importance of microcirculatory disturbances in the pathogenesis of pancreatitis. | 2001 | Zentralbl Chir | pmid:11753796 |
| Biffl WL et al. | Neutrophil apoptosis is delayed by trauma patients' plasma via a mechanism involving proinflammatory phospholipids and protein kinase C. | 2001 | Surg Infect (Larchmt) | pmid:12593704 |
| Kuijpers TW et al. | The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. | 2001 | Clin. Exp. Immunol. | pmid:11298128 |
| Teeling JL et al. | Intravenous immunoglobulin preparations induce mild activation of neutrophils in vivo via triggering of macrophages--studies in a rat model. | 2001 | Br. J. Haematol. | pmid:11298603 |
| Teather LA et al. | Differential interaction of platelet-activating factor and NMDA receptor function in hippocampal and dorsal striatal memory processes. | 2001 | Neurobiol Learn Mem | pmid:11300737 |
| Aiboshi J et al. | Blood transfusion and the two-insult model of post-injury multiple organ failure. | 2001 | Shock | pmid:11303730 |
| Ilveskero S et al. | Procoagulant activity on platelets adhered to collagen or plasma clot. | 2001 | Arterioscler. Thromb. Vasc. Biol. | pmid:11304482 |
| Chłopicki S et al. | Residual pulmonary neutrophils are involved in vaso- and bronchoconstrictor responses to platelet activating factor in the isolated buffer-perfused rat lung. | 2000 May-Jun | Pol J Pharmacol | pmid:11055579 |
| Iglesias-De La Cruz MC et al. | Phenotypic modifications of human mesangial cells by extracellular matrix: the importance of matrix in the contractile response to reactive oxygen species. | 2000 Mar-Apr | Exp. Nephrol. | pmid:10729749 |
| Bastos da Silva M et al. | In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. | 2000 Mar-Apr | Vet. Res. | pmid:10779205 |
| Sibelius U et al. | Staphylococcal alpha-toxin provokes coronary vasoconstriction and loss in myocardial contractility in perfused rat hearts: role of thromboxane generation. | 2000 Jan 4-11 | Circulation | pmid:10618308 |
| Zouki C et al. | The anti-inflammatory peptides, antiflammins, regulate the expression of adhesion molecules on human leukocytes and prevent neutrophil adhesion to endothelial cells. | 2000 | FASEB J. | pmid:10698973 |
| Hidi R et al. | Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis. | 2000 | Eur. Respir. J. | pmid:10706503 |
| Chen LW et al. | Differential regulation of Ca2+ influx by fMLP and PAF in human neutrophils: possible involvement of store-operated Ca2+ channel. | 2000 | Shock | pmid:10718373 |
| Wang WJ et al. | [Effects of musk glucoprotein on PAF production and cytosolic Ca2+ level in rat polymorphonuclear leukocytes in vitro]. | 2000 | Zhongguo Zhong Yao Za Zhi | pmid:12525061 |
| Manabe H et al. | The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs. | 2000 | Pulm Pharmacol Ther | pmid:10718985 |
| Sun Z et al. | Beneficial effects of lexipafant, a PAF antagonist on gut barrier dysfunction caused by intestinal ischemia and reperfusion in rats. | 2000 | Dig Surg | pmid:10720833 |
| Vallee RB et al. | The role of cytoplasmic dynein in the human brain developmental disease lissencephaly. | 2000 | Biochim. Biophys. Acta | pmid:10722879 |
| Weintraub ST et al. | Mass spectrometric analysis of platelet-activating factor after isolation by solid-phase extraction and direct derivatization with pentafluorobenzoic anhydride. | 2000 | J. Am. Soc. Mass Spectrom. | pmid:10689672 |
| Nilsson G et al. | Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. | 2000 | Immunology | pmid:10692052 |
| De Plaen IG et al. | Lipopolysaccharide activates nuclear factor kappaB in rat intestine: role of endogenous platelet-activating factor and tumour necrosis factor. | 2000 | Br. J. Pharmacol. | pmid:10694237 |
| Wang WZ et al. | Platelet-activating factor contributes to postischemic vasospasm. | 2000 | J. Surg. Res. | pmid:10729242 |
| Ishii S and Shimizu T | Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. | 2000 | Prog. Lipid Res. | pmid:10729607 |
| Berthou C et al. | Interferon-gamma-induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis. | 2000 | Blood | pmid:10733503 |
| Kaul DK et al. | Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor. | 2000 | Blood | pmid:10627437 |
| Martin-Chouly CA et al. | Modulation of PAF production by incorporation of arachidonic acid and eicosapentaenoic acid in phospholipids of human leukemic monocyte-like cells THP-1. | 2000 | Prostaglandins Other Lipid Mediat. | pmid:10751643 |
| Zaitseva L et al. | Role of eicosanoids in regulation of macrophage phagocytic functions by platelet-activating factor during endotoxic shock. | 2000 | Bull. Exp. Biol. Med. | pmid:11177271 |
| Miike S et al. | Platelet-activating factor activates mitogen-activated protein kinases through the activation of phosphatidylinositol 3-kinase and tyrosine kinase in human eosinophils. | 2000 | J. Leukoc. Biol. | pmid:10648006 |
| Kecskeméti V and Balogh I | The role of platelet-activating factor (PAF) antagonists and nitric oxide in cardiac actions of PAF. Electrophysiological and morphological study. | 2000 | J. Physiol. Pharmacol. | pmid:11192945 |
| Dichmann S et al. | Adenosine triphosphate-induced oxygen radical production and CD11b up-regulation: Ca(++) mobilization and actin reorganization in human eosinophils. | 2000 | Blood | pmid:10648411 |
| Burns AR et al. | Analysis of tight junctions during neutrophil transendothelial migration. | 2000 | J. Cell. Sci. | pmid:10591624 |
| McManus LM and Pinckard RN | PAF, a putative mediator of oral inflammation. | 2000 | Crit. Rev. Oral Biol. Med. | pmid:12002818 |
| Emerson M et al. | Characterization and functional significance of calcium transients in the 2-cell mouse embryo induced by an autocrine growth factor. | 2000 | J. Biol. Chem. | pmid:10764773 |
| Munakata M et al. | Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure. | 2000 | Jpn. J. Thorac. Cardiovasc. Surg. | pmid:10769990 |
| Connolly AB and Vernon DR | Manipulations of the metabolic response for management of patients with severe surgical illness: review. | 2000 | World J Surg | pmid:10773122 |
| Shindou H et al. | Roles of cytosolic phospholipase A(2) and platelet-activating factor receptor in the Ca-induced biosynthesis of PAF. | 2000 | Biochem. Biophys. Res. Commun. | pmid:10814544 |
| Mizutani Y et al. | Cloning and expression of rat neutral sphingomyelinase: enzymological characterization and identification of essential histidine residues. | 2000 | Biochim. Biophys. Acta | pmid:10832103 |
| Oshiro T et al. | Characterization of platelet-activating factor-induced cytosolic calcium mobilization in human eosinophils. | 2000 | Clin. Exp. Allergy | pmid:10792362 |
| Ibe BO et al. | Platelet-activating factor receptors in lamb lungs are downregulated immediately after birth. | 2000 | Am. J. Physiol. Heart Circ. Physiol. | pmid:10749711 |
| Vincent JL et al. | Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis. | 2000 | Crit. Care Med. | pmid:10752807 |
| Lendvai N et al. | Mechanism for the isotype dependence of antibody-mediated toxicity in Cryptococcus neoformans-infected mice. | 2000 | J. Immunol. | pmid:10754337 |
| Porta C et al. | Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. | 2000 | Haematologica | pmid:10942928 |
| Hickey MJ et al. | L-selectin facilitates emigration and extravascular locomotion of leukocytes during acute inflammatory responses in vivo. | 2000 | J. Immunol. | pmid:11120848 |
| Kaplan R et al. | Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease. | 2000 | Br. J. Haematol. | pmid:11122160 |
| Bussolati B et al. | IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE). | 2000 | Clin. Exp. Immunol. | pmid:11122257 |
| Kelly RF | Current strategies in lung preservation. | 2000 | J. Lab. Clin. Med. | pmid:11128744 |
| Alloatti G et al. | Role of NO and PAF in the impairment of skeletal muscle contractility induced by TNF-alpha. | 2000 | Am. J. Physiol. Regul. Integr. Comp. Physiol. | pmid:11080081 |
| Tjoelker LW and Stafforini DM | Platelet-activating factor acetylhydrolases in health and disease. | 2000 | Biochim. Biophys. Acta | pmid:11080681 |
| Tanaka Y et al. | Possible involvement of endothelium-derived hyperpolarizing factor (EDHF) in the depressor responses to platelet activating factor (PAF) in rats. | 2000 | Br. J. Pharmacol. | pmid:11082118 |
| Chroni A and Mavri-Vavayanni M | Characterization of a platelet activating factor acetylhydrolase from rat adipocyte. | 2000 | Life Sci. | pmid:11105997 |
| Wechsung E and Houvenaghel A | Involvement of platelet activating factor in the endotoxin-induced effects on gastrointestinal electrical activity and some haematological parameters in the conscious miniature pig. | 2000 | J. Vet. Pharmacol. Ther. | pmid:11107007 |
| Lonardoni MV et al. | Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. | 2000 | Infect. Immun. | pmid:11035745 |
| Shibata K et al. | Mediation by platelet-activating factor of 12-hydroxyeicosatetraenoic acid-induced cytosolic free calcium concentration elevation in neutrophils. | 2000 | Prostaglandins Other Lipid Mediat. | pmid:11060901 |
| Dubois MJ and Vincent JL | Clinically-oriented therapies in sepsis: a review. | 2000 | J. Endotoxin Res. | pmid:11521072 |
| Davenpeck KL et al. | Activation of human leukocytes reduces surface P-selectin glycoprotein ligand-1 (PSGL-1, CD162) and adhesion to P-selectin in vitro. | 2000 | J. Immunol. | pmid:10946308 |
| Martin M et al. | [Antiretroviral ant anti-inflammatory properties of a novel platelet activation factor antagonist, PMS-601]. | 2000 | Pathol. Biol. | pmid:10949851 |
| Countryman NB et al. | Evidence for involvement of the epidermal platelet-activating factor receptor in ultraviolet-B-radiation-induced interleukin-8 production. | 2000 | J. Invest. Dermatol. | pmid:10951245 |
| Soeki T et al. | Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction. | 2000 | Jpn. Circ. J. | pmid:10952148 |
| Henig NR et al. | Effect of recombinant human platelet-activating factor-acetylhydrolase on allergen-induced asthmatic responses. | 2000 | Am. J. Respir. Crit. Care Med. | pmid:10934081 |
| Haribabu B et al. | Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. | 2000 | J. Exp. Med. | pmid:10934231 |
| Miyatake T et al. | Analysis of cardiac function during hyperacute rejection: effects of PAF antagonist, TXA(2) inhibitor/antagonists, and nitroglycerin. | 2000 | Transplant. Proc. | pmid:10936319 |
| Raible DG et al. | Hydrogen peroxide release from human eosinophils on fibronectin: scopoletin enhances eosinophil activation. | 2000 | Free Radic. Biol. Med. | pmid:10938462 |
| Baskova I et al. | Inhibition of induced and spontaneous platelet aggregation by destabilase from medicinal leech. | 2000 | Platelets | pmid:10938885 |
| Pávó I et al. | Interactions of pro-inflammatory and vasoactive mediators with nitric oxide in the regulation of rat vascular permeability during laparotomy. | 2000 | Eur. J. Pharmacol. | pmid:10940373 |
| Wilks J | The impact of the pill on implantation factors--new research findings. | 2000 | Ethics Med | pmid:15015518 |
| Kusuhara H et al. | Y-24180, an antagonist of platelet-activating factor, suppresses interleukin 5 production in cultured murine th(2)cells and human peripheral blood mononuclear cells. | 2000 | Cytokine | pmid:10880261 |
| Tektonidou MG et al. | Clinical importance of antibodies against platelet activating factor in antiphospholipid syndrome manifestations. | 2000 | Eur. J. Clin. Invest. | pmid:10886305 |
| Aihara M et al. | Interaction between neurone and microglia mediated by platelet-activating factor. | 2000 | Genes Cells | pmid:10886367 |
| Folch E et al. | H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis. | 2000 | Free Radic. Biol. Med. | pmid:10889459 |
| Huo LJ and Yang ZM | Effects of platelet activating factor on capacitation and acrosome reaction in mouse spermatozoa. | 2000 | Mol. Reprod. Dev. | pmid:10862011 |
| Cavallo-Perin P et al. | Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria. | 2000 | Nephrol. Dial. Transplant. | pmid:10862637 |
| Bae K et al. | Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases. | 2000 | J. Biol. Chem. | pmid:10867005 |
| Alappatt C et al. | Acute keratinocyte damage stimulates platelet-activating factor production. | 2000 | Arch. Dermatol. Res. | pmid:10867814 |
| Suzuki S et al. | The roles of platelet-activating factor and endothelin-1 in renal damage after total hepatic ischemia and reperfusion. | 2000 | Transplantation | pmid:10868624 |
| Wagner F et al. | Ether lipids in the cell membrane of Mycoplasma fermentans. | 2000 | Eur. J. Biochem. | pmid:11012682 |
| Yildirim G et al. | Does the platelet-activating factor affect the antioxidant defense system? The possible role of hyperbaric oxygenation. | 2000 | Biol Trace Elem Res | pmid:11318001 |